{"prompt": "['Simultaneous mRNA COVID-19 and IIV4 Vaccination Study', 'Version 2.0', 'September 17, , 2021', '5.1.1 Primary Two-Dose COVID-19 Series Schedule of Events', 'Table 5: BNT162b2 (Pfizer-BioNTech) Schedule of Events', 'Un-', 'Procedure', 'Visit 1', 'Visit 1a', 'Visit 2', 'Visit 2a', 'Visit 3', 'Visit 3a', 'Visit 4', 'Visit 5', 'Visit 6', 'Scheduled', 'Phone/Text', 'Phone/Text', 'Phone/Text', 'Clinic', '/Email/Data', 'Clinic', '/Email/Data', 'Clinic', '/Email/Data', 'Clinic', 'Clinic', 'Phone', 'Clinic', 'Review1,2', 'Review1,2,3', 'Review1,2,3', 'Estimated', 'Study Day', '1', '1-7', '15', '15-21', '22', '22-28', '36', '50', '121', '(Relative to Visit 1)', 'Time Following Visit 1', '0', '0-6', '14 [+/-2]', '14-20', '21 [+/-4]', '21-27', '120 (+/-14)', '(Days) [Window]', 'Time Following Visit 2', '21 [+/-4]', '(Days) [Window]', 'Time Following Visit 3', '28 [+/-4]', '(Days) [Window]', 'Informed consent &', 'Medical Release of', 'X', 'Information', 'Review Eligibility Criteria', 'X', 'Review Temporary Delay', 'X', 'X', 'X', 'Criteria', 'Demographic and Health', 'X', 'History', 'Influenza and COVID-19', 'X', 'Vaccination History', 'Obtain unsolicited adverse', 'events', 'X', 'X', 'X', 'Obtain SAE and AESI', 'information', 'X', 'X', 'X', 'X', 'X', 'X', 'Concomitant medications', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'HRQOL measure', 'X', 'X', 'Measure temperature', 'X', 'X', 'X', 'X', 'Venipuncture', 'X', 'X', 'X', 'X', 'Randomization', 'X', 'Vaccination with COVID-', 'X4', 'X5', '19 vaccine', 'Vaccination with IIV4 or', 'X', 'X', 'Placebo', '27']['Simultaneous mRNA COVID-19 and IIV4 Vaccination Study', 'Version 2.0', 'September 17, 2021', 'Table 5: BNT162b2 (Pfizer-BioNTech) Schedule of Events', 'Un-', 'Procedure', 'Visit 1', 'Visit 1a', 'Visit 2', 'Visit 2a', 'Visit 3', 'Visit 3a', 'Visit 4', 'Visit 5', 'Visit 6', 'Scheduled', 'Phone/Text', 'Phone/Text', 'Phone/Text', 'Clinic', '/Email/Data', 'Clinic', '/Email/Data', 'Clinic', '/Email/Data', 'Clinic', 'Clinic', 'Phone', 'Clinic', 'Review1,2,3', 'Review1,2,3', 'Review1,2,3', 'Estimated', 'Study Day', '1', '1-7', '15', '15-21', '22', '22-28', '36', '50', '121', '(Relative to Visit 1)', 'Time Following Visit 1', '0', '0-6', '14 [+/-2]', '14-20', '21 [+/-4]', '21-27', '120 (+/-14)', '(Days) [Window]', 'Time Following Visit 2', '21 [+/-4]', '(Days) [Window]', 'Time Following Visit 3', '28 [+/-4]', '(Days) [Window]', 'Memory Aid, Link to', 'electronic symptom diary', 'X', 'X', 'X', 'given to participant', 'Assess for any immediate', 'X', 'reactogenicity symptoms', 'X', 'X', 'Electronic Diary Review\u00b2', 'X', 'X', 'X', 'Complete electronic or', 'X', 'paper symptom diary1', 'X', 'X', '1 Symptom diary (solicited local and systemic reactogenicity events) to be completed by participant on Days 1-7 after vaccination.', '2', 'Participants completing paper diary only will be called at days 3 [+2], 17[+2], and 24 [+2] as a reminder and to prompt to bring paper diary to next visit', '3 Electronic diary records will be reviewed by study staff at days 3, 8, 17, 22, 24, and 29 for completion or issues.', '4 Receipt of BNT162b2 within 8 hours of enrollment is permitted', '5. Receipt of BNT162b2 within 36 hours prior to study visit is permitted', '28']\n\n###\n\n", "completion": "END"}